STERIS plc (NYSE:STE) Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC decreased its position in STERIS plc (NYSE:STE) by 16.2% during the 4th quarter, Holdings Channel reports. The firm owned 1,413,306 shares of the medical equipment provider’s stock after selling 273,276 shares during the quarter. Janus Henderson Group PLC’s holdings in STERIS were worth $290,517,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of STE. Avalon Trust Co acquired a new stake in STERIS in the fourth quarter valued at $30,000. Human Investing LLC purchased a new stake in STERIS during the 4th quarter worth about $31,000. Anfield Capital Management LLC increased its position in STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 91 shares in the last quarter. Manchester Capital Management LLC increased its position in STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 137 shares in the last quarter. Finally, Brown Brothers Harriman & Co. increased its position in STERIS by 66.7% during the 4th quarter. Brown Brothers Harriman & Co. now owns 220 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 88 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Performance

Shares of NYSE:STE opened at $226.54 on Monday. The company has a market cap of $22.26 billion, a P/E ratio of 48.10 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a one year low of $200.98 and a one year high of $248.24. The business’s 50-day simple moving average is $223.40 and its 200 day simple moving average is $218.80.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be issued a dividend of $0.57 per share. The ex-dividend date of this dividend is Tuesday, June 10th. This represents a $2.28 annualized dividend and a dividend yield of 1.01%. STERIS’s payout ratio is currently 48.41%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on STE. Stephens upgraded STERIS to a “strong-buy” rating in a research report on Thursday, May 1st. Piper Sandler raised their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research report on Monday, April 7th. Finally, JMP Securities restated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research report on Thursday, April 10th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, STERIS presently has a consensus rating of “Buy” and an average price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.